Sika Interplant Systems Share Price Target 2026, 2027, 2028, 2029, 2030

Sika Interplant share price today

Sika Interplant Systems (BSE: 523606) is a Bengaluru engineering house that works on the unglamorous middle of India’s aerospace and defence supply chain: systems integration, precision manufacturing, maintenance and repair support, and programme-specific engineering for defence and aviation customers. It is not a platform prime and it is not a component commodity supplier. It sits between them, which is a good place to earn high returns and a difficult place to forecast. It is unrelated to the Swiss construction-chemicals group of a similar name.

At the 6 August 2026 cut-off the share closed at ₹1,112.75, a reconciled market capitalisation near ₹2,354 crore on trailing EPS of ₹16.60. The quote above will have moved; the analysis is pinned to that session.

The investment question here is almost entirely about price. The business earns 34.56% on capital employed with no promoter pledge and has compounded sales at roughly 21.5% over five years. It was also trading at about 67 times trailing earnings and 15 times book. Very little has to go wrong for that multiple to hurt.

What the company actually does

Indian defence indigenisation is a genuine multi-year demand story, and it has produced a genuine multi-year valuation story alongside it. Separating the two requires being specific about where Sika earns its money.

Activity	What it involves	Economic character
Systems integration	Assembling and qualifying subsystems to a customer specification	Engineering-led, programme-linked, high value per contract
Precision manufacturing	Machined and fabricated parts to aerospace tolerance	Capital-light relative to a full production line
Maintenance and repair	Overhaul and support for installed equipment	Annuity-like where an installed base exists
Programme engineering	Design and development support on specific platforms	Sticky, but revenue recognition follows milestones
Representation and support	Acting for overseas equipment suppliers in India	Low capital, variable and relationship-dependent

Two things follow from that mix. First, returns are high because the company sells engineering capability rather than tonnes of metal, and the capital employed is correspondingly small. Second, revenue is lumpy, because milestone-based recognition on programme work means a delay in one contract moves a quarter.

Q1 FY27 showed exactly that lumpiness

The June 2026 quarter was approved on 14 August 2026, after our cut-off date. On a consolidated basis it reported sales of about ₹42.86 crore and net profit of roughly ₹8.40 crore. Coverage of the result attributed a weaker outcome to supply-chain disruption that delayed order execution and therefore revenue recognition.

Q1 FY27 observation	Detail	Reading
Consolidated sales	About ₹42.86 Cr	Roughly ₹171 Cr annualised
Consolidated net profit	About ₹8.40 Cr	Roughly a quarter of the trailing annual figure
Implied net margin	Close to 20%	High, and consistent with the engineering-led mix
Stated cause of weakness	Supply-chain disruption	Execution timing rather than demand loss
Approval date	14 August 2026	After the 6 August cut-off used throughout this article

We have deliberately not folded that quarter into the valuation base, because it falls outside the fixed cut-off. Readers should look at it directly. A single delayed quarter in a milestone-recognition business is unremarkable in itself; what matters is whether the deferred revenue reappears in the September and December quarters or quietly disappears.

Trailing EPS of ₹16.60 across roughly 2.1158 crore shares implies annual profit near ₹35 crore, which sits consistently against a quarterly figure of ₹8.40 crore. Annualising the June quarter’s sales gives roughly ₹171 crore of revenue against a market capitalisation of ₹2,354 crore — close to fourteen times sales, which is the same valuation warning the earnings multiple gives, in a different currency.

Order-book visibility is the weakest link

The most recent order-book figure we can source cleanly is dated: roughly ₹264 crore of orders secured from the start of FY25, disclosed in December 2024. That is a real number, and it is also nearly two years old at the time of writing.

For a company valued at ₹2,354 crore, an order book of that order of magnitude — if it is still broadly the right scale — represents a fraction of the market capitalisation. More importantly, we cannot construct a current, reliable picture of contracted revenue from public disclosure. Defence engineering businesses live or die on the order pipeline, and the absence of regular, quantified order-book reporting is a material gap when the shares trade at 67 times earnings.

This is the single largest reason for caution on this name. It is not an allegation that the pipeline is weak. It is an observation that an investor paying a premium multiple for future execution cannot currently see what is contracted.

The return ratios are genuinely good

Quality measure	6 August 2026 value	Reading
Return on equity	25.13%	Strong, achieved without leverage worth noting
Return on capital employed	34.56%	Well above the 27.07% five-year average
Operating margin	21.43%	Healthy for engineering services and integration
Five-year sales CAGR	21.52%	Real growth, not an accounting artefact
Five-year profit CAGR	24.65%	Growth broadly matched by profit
Promoter pledge	0%	No pledged holding at the cut-off

Note that unlike several names in this batch, profit growth of 24.65% is close to sales growth of 21.52%. The earnings compounding here has come mostly from selling more, not from expanding margin — which is the healthier pattern, and the main reason we would rather own this business at a sensible price than dismiss it.

Valuation: the whole argument in one table

At ₹1,112.75 the shares traded at roughly 67 times trailing earnings and 15 times book, for a PEG near 2.72. The 52-week range ran ₹755.05 to ₹1,365.00, so the cut-off price sat about 18.5% below the high.

Valuation metric	6 August 2026 value	Basis
Share price	₹1,112.75	Exchange close on the cut-off date
Reconciled market capitalisation	₹2,354 Cr	Price times about 2.1158 crore shares
Recalculated P/E	67.03×	₹1,112.75 divided by trailing EPS of ₹16.60
Recalculated price to book	15.16×	₹1,112.75 divided by ₹73.40 book value per share
Recalculated PEG	About 2.72	P/E divided by the 24.65% five-year profit CAGR
Dividend yield	About 0.31%	Token; earnings are retained
52-week range	₹755.05 – ₹1,365.00	Cut-off price about 18.5% below the high

A PEG of 2.72 means the market was paying roughly two-and-three-quarter times the historical growth rate. For that to work out, growth has to accelerate from an already good 21.5%, and the multiple has to stay near where it is. Defence sentiment can sustain that for years. It can also reverse in a quarter.

The available valuation fields were captured on a different day from the price we fixed, so market capitalisation, P/E, price to book, PEG and yield were all recomputed against the same ₹1,112.75 close and roughly 2.1158 crore shares.

A note on the bear case

We want to be explicit about a limitation in the scenario grid below. The bear case applies an exit multiple of 35 times earnings. That is roughly half the current multiple, and it is still, in absolute terms, a premium rating for a small engineering company.

In other words the downside modelled here is a de-rating toward a still-expensive level, not a de-rating to a cheap one. If defence sentiment genuinely turns, or if order execution disappoints for several consecutive quarters, a multiple in the high teens or twenties is entirely possible, and the resulting price would be well below our bear row. Readers should treat the bear column as a moderate adverse case rather than a worst case.

Valuation framework

The model compounds trailing EPS of ₹16.60 from the cut-off, applying 147/365 of a year’s growth to the 2026 row and one further full year to each later row, then an exit price-to-earnings multiple. Values round to the nearest ₹5 and exclude dividends.

Scenario	Annual EPS growth	Exit P/E	Operating interpretation
Bear	12%	35×	Execution delays persist and the premium partly unwinds
Base	20%	50×	Growth continues near the historical rate at a still-rich multiple
Bull	27%	65×	Indigenisation orders accelerate and the market keeps paying up

Sika Interplant share price target 2026 to 2030

The grid above turns those assumptions into yearly figures. Because the starting multiple is so high, the exit multiple dominates the outcome far more than in a typical scenario table on this site — which is itself the argument for waiting rather than paying up.

What would change the thesis

The case strengthens if the company begins disclosing a current, quantified order book with execution timelines, if the revenue deferred by supply-chain disruption reappears in the following two quarters, if margin holds above 20% as scale increases, and if indigenisation contracts convert into repeat programme work rather than one-off supply.

It weakens if order visibility stays opaque, if delayed revenue does not materialise, if working capital lengthens as programme milestones slip, or if the defence-sector re-rating that carried the multiple to 67 times reverses for reasons entirely outside the company’s control.

Quarterly monitoring scorecard

Question	Constructive evidence	Warning sign
Did deferred revenue return?	September and December quarters recover the shortfall	Two more quarters of delayed recognition
Is the order book visible?	Regular quantified disclosure with timelines	Continued silence on contracted revenue
Is growth still real?	Sales growth stays near the 21.5% five-year rate	Growth slows while the multiple holds
Is margin holding?	Operating margin above 20%	Compression as lower-value work is taken on
Is capital still productive?	ROCE stays above the 27.07% five-year mean	Return ratios fall as capital employed rises
Is the premium justified?	Repeat programme wins from named customers	Valuation supported only by sector sentiment

What to weigh at the current price

There is a good business here. Returns on capital in the mid-thirties, growth that has come from selling more rather than from margin tricks, no pledge, and a position in a supply chain that India is deliberately trying to build out. If it were available at twenty-five times earnings this would be a straightforward conversation.

At sixty-seven times, with an order book we cannot currently see and a June quarter already disrupted, the price is doing the arguing rather than the business. Our position is to keep this on the watch list and require either a materially lower entry point or genuine order-book disclosure before acting. Paying a premium multiple for execution you cannot verify is the specific mistake this sector has punished before.

FAQ

What is the Sika Interplant share price target for 2030?

The grid above sets out bear, base and bull values from trailing EPS, a growth assumption and an exit multiple. Note that even the bear column applies a 35 times exit multiple, so it is a moderate adverse case rather than a worst case.

What does Sika Interplant Systems do?

Systems integration, precision manufacturing, maintenance and repair support and programme engineering for aerospace and defence customers, mostly from Bengaluru. It is a supply-chain participant rather than a platform prime.

Is Sika Interplant related to the Swiss company Sika?

No. Sika Interplant Systems is an independent Indian aerospace and defence engineering company and has no connection to the Swiss construction-chemicals group that shares part of its name.

Why is the valuation a concern?

At roughly 67 times trailing earnings and 15 times book, with a PEG near 2.72, the market was paying well ahead of the historical growth rate while current order-book disclosure remained limited.

What happened in Q1 FY27?

Consolidated sales were about ₹42.86 crore and net profit about ₹8.40 crore, with coverage attributing the weakness to supply-chain disruption that delayed order execution and revenue recognition. The result was approved after our 6 August cut-off and is not in the valuation base.

When does Sika Interplant report its next result?

Check the results calendar and confirm the board-meeting date from the company’s own BSE filing before relying on any estimate.

Related research

• HAL share price target
• HBL Engineering share price target
• Solar Industries share price target

Sources and methodology

• Sika Interplant Systems on Screener
• Sika Aerospace and Defence investor page
• Sika Interplant Q4 FY26 result analysis
• Sika Interplant order-book disclosure coverage

Return and margin metrics are Screener figures captured on 6 August 2026; the price and 52-week range are exchange closing data for the same session, and all per-share ratios were recomputed against that price. The order-book figure quoted is explicitly dated to its December 2024 disclosure and is not presented as a current position, because we could not source a current one. June-quarter results were approved after the cut-off and are described but excluded from the model.

---

This article is research and education, not personalised investment advice or a recommendation to transact. Gale is not a SEBI-registered investment adviser. Price targets are scenario arithmetic, not promises. Verify current filings, liquidity, corporate actions and suitability, and consult a registered adviser before acting.